cGAS: bridging immunity and metabolic regulation

Area of Science:

• Immunometabolism
• Cellular Signaling
• Molecular Biology

Background:

• Cyclic guanosine monophosphate-adenosine monophosphate (AMP) synthase (cGAS) is primarily known as a cytosolic DNA sensor involved in innate immunity.
• Emerging evidence suggests cGAS has roles beyond immunity, particularly within metabolic tissues.
• Adipose tissue dysfunction is linked to metabolic disorders, including inflammation and insulin resistance.

Purpose of the Study:

• To reframe the understanding of cGAS function, positioning it at the nexus of immunity and metabolism.
• To explore the multifaceted roles of cGAS in adipocytes and other metabolic tissues.
• To identify potential therapeutic strategies targeting cGAS in metabolic diseases.

Main Methods:

• Review of recent advances in cGAS research, focusing on its non-canonical functions.
• Analysis of cGAS involvement in adipose tissue, particularly in response to mitochondrial stress.
• Discussion of STING-dependent and STING-independent pathways modulated by cGAS.

Main Results:

• cGAS functions as a metabolic sentinel in adipose tissue, responding to mitochondrial stress.
• cGAS activity in adipocytes contributes to inflammation, insulin resistance, and energy imbalance.
• cGAS exerts its metabolic effects through both STING-dependent and STING-independent mechanisms, involving autophagy and transcriptional changes.

Conclusions:

• cGAS plays a critical role in integrating immune and metabolic signaling within adipose tissue.
• Understanding cGAS's role in metabolic health opens new avenues for therapeutic interventions.
• Further research is warranted to fully elucidate cGAS's complex functions and therapeutic potential in metabolic diseases.